Home/Filings/3/0000902664-20-001369
3//SEC Filing

Sailing Capital Overseas Investments Fund, LP 3

Accession 0000902664-20-001369

CIK 0001378624other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 4:01 PM ET

Size

5.1 KB

Accession

0000902664-20-001369

Insider Transaction Report

Form 3
Period: 2020-02-21
Holdings
  • Common Stock

    (indirect: See Footnote)
    1,712,920
Footnotes (1)
  • [F1]The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.

Documents

1 file

Issuer

Cellular Biomedicine Group, Inc.

CIK 0001378624

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001731251

Filing Metadata

Form type
3
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:01 PM ET
Size
5.1 KB